annual review

Using the Science of Partnerships to Drive Patient Impact

Multimedia with summary

In Africa, patients can outnumber doctors 3,000 to 1. That’s one of the reasons why Pfizer is dedicated to fostering innovative partnerships that allow us to mobilize resources to help find new and unique solutions that increase access to needed health care.

Our colleague Willy Soriney, Strategic Partnership Director, works in Kenya using the science of partnerships to look for new approaches that can speed access to critical health interventions and fill unmet medical needs, bringing quality health care to those who need it most.

Tackling Antimicrobial Resistance with The Power of Science

Multimedia with summary

Antimicrobial resistance (AMR), or the ability of a bacterium, virus, or fungus to develop resistance to the medicines commonly used to treat them, is one of the leading global public health threats today. Currently, AMR causes more than 700,000 deaths annually. If left unchecked, this number is expected to rise to 10 million deaths annually by 2050. In collaboration with the infectious disease community, we are working to develop solutions that address and help treat the serious and growing AMR crisis.

Advancing The Power of Science Behind Immuno-Oncology

Multimedia with summary

Pfizer’s advances in oncology demonstrate the Power of Scientific innovation to help improve lives, particularly the power of Immuno-oncology (I-O). Immuno-oncology uses the natural ability of the body’s immune system to recognize and fight tumors. This past year, Pfizer continued to advance its work in I-O because we recognize the urgency of finding anti-cancer alternatives to help patients who need them.

Giving Millions a Shot

Blog

We are proud to work with Gavi, the Vaccine Alliance and the United Nations' (UN) Shot@Life campaign to ensure Pfizer’s life-saving vaccines reach those who need them most.

Using the Power of Partnerships to Support Global Goal 5: Gender Equality

Multimedia with summary

At Pfizer, we are proud to support the United Nations Sustainable Development Goals (SDGs), specifically Goal 5: Gender Equality. Equality across genders is fundamental to advancing all 17 of the SDGs, which in turn is connected to advancing global health.

This year and every year, Pfizer harnesses the power of partnerships with various organizations to help empower and mobilize women in need. 

Investigating Groundbreaking Treatments for Rare Disease

Multimedia with summary

Gene therapy has the potential to transform how we manage rare genetic diseases like hemophilia, Duchenne Muscular Dystrophy and others by addressing their root cause – genetic mutations.

The Power of Science behind gene therapy inspires our colleagues, like Bob Smith, SVP, Global Gene Therapy Business, to investigate this groundbreaking technology that could, if successful, bring disease-modification to millions of patients worldwide.

Pfizer On Track to Reduce Water Withdrawal Globally

Blog

Today on World Water Day, we are reflecting on all the ways Pfizer is working to reduce and preserve water across our company, contributing to the achievement of Sustainable Development Goal 6: Clean Water and Sanitation.

Pfizer Releases 2017 Annual Review

Blog

Pfizer released its 2017 Annual Review, which highlights how The Power of Science drives every aspect of Pfizer’s business in its mission to deliver innovative medicines and vaccines that help improve health and well-being at every stage of life.

This year’s integrated report uses the lens of our colleagues to illustrate how The Power of Science inspires the work they do every day. Highlights include:

Pfizer’s Progress on 2020 Reduced Water Use Goals

Multimedia with summary

Pfizer believes in the importance of reducing human impact on the environment. As part of this, the company has pledged to reduce water use by five percent by 2020.

See Pfizer’s progress toward reduced water consumption in our annual review at www.pfizer.com/annual.

 

Stockland Releases Its 2017 Annual Review and Sustainability Reporting

Article

Stockland has released its FY17 Annual Review and Sustainability Reporting, which highlight its continued leadership and ongoing achievements in sustainability.
 
Mark Steinert, Managing Director and CEO Stockland, said: “These reports demonstrate the shared value we create for our securityholders, customers, community and the environment through the world-leading sustainability initiatives we’re implementing across our business. 
 

Pages

Subscribe to annual review